ASLAN Pharmaceuticals Ltd (ASLN)
Aslan Pharmaceuticals Ltd. is a clinical-stage immunology biopharmaceutical company, which develops novel therapeutics. It focuses on atopic dermatitis, other immunology indications and autoimmune disease. Its pipeline includes ASLAN003 and Eblasakimab. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.
Address
83 CLEMENCEAU AVENUE
SINGAPORE, U0 239920
Founded
2010
Number of Employees
35
Website
http://www.aslanpharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)